Efficacy of Ipilimumab and Nivolumab Rechallenge in a Long-Term Melanoma Survivor: A Case Report

A. Maria Vromans; Maria Constantinou

doi:10.12659/AJCR.950432

09 April 2026 : Case report USA

Efficacy of Ipilimumab and Nivolumab Rechallenge in a Long-Term Melanoma Survivor: A Case Report

Unusual clinical course, Unusual or unexpected effect of treatment

A. Maria Vromans

^{ABEF 1*}, Maria Constantinou^{ABEF 2}

DOI: 10.12659/AJCR.950432

Am J Case Rep 2026; 27:e950432

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Schematic of patient treatment course. Red – progression of disease on treatment; Blue – regression of disease on treatment; Purple – recurrence-free survival period.

Back to the Article

Efficacy of Ipilimumab and Nivolumab Rechallenge in a Long-Term Melanoma Survivor: A Case Report

Your Privacy